The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Arachidonic Acid Oxygenation by COX-1 and COX-2
Open accessAbstract
cyclooxygenase protein or the gene that codes for it non-steroidal anti-inflammatory drugs prostaglandin G2 Prostaglandins were discovered in human semen in 1930, but their low concentrations and instability precluded identification for nearly 30 years (for a brief historical review, see Ref. 1Bindra J.S. Bindra R. Prostaglandin Synthesis. Academic Press, New York1977: 7-22Crossref Google Scholar). Once they were identified, it was clear they arose from polyunsaturated fatty acids by a complex series of reactions involving oxygenation, cyclization, and the generation of five chiral centers from an achiral substrate. The mechanism of prostaglandin biosynthesis was outlined in 1967 by Hamberg and Samuelsson (2Hamberg M. Samuelsson B. J. Biol. Chem. 1967; 242: 5336-5343Abstract Full Text PDF PubMed Google Scholar), and the basic tenets have been confirmed in subsequent studies. The key step in their proposed mechanism was the formation of bicyclic peroxides (endoperoxides) as the initial products of polyunsaturated fatty acid oxygenation (Fig. 1). The term cyclooxygenase (COX)1 2The term cyclooxygenase is used to describe the enzyme activity or to refer to the active site for that activity on the protein.was coined to describe the enzyme that carried out this complex chemical transformation, and its role was confirmed by the isolation of prostaglandin endoperoxides in 1973 (3Hamberg M. Samuelsson B. Proc. Natl. Acad. Sci. U. S. A. 1973; 70: 899-903Crossref PubMed Scopus (570) Google Scholar, 4Nugteren D.H. Hazelhof E. Biochim. Biophys. Acta. 1973; 326: 448-461Crossref PubMed Scopus (635) Google Scholar). In addition to catalyzing a fascinating metabolic transformation, COX is an enormously important pharmacological target. Vane reported in 1971 (5Vane J.R. Nat. New Biol. 1971; 231: 232-235Crossref PubMed Scopus (7348) Google Scholar) that non-steroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandin formation and demonstrated that their relative inhibitory potency in vitro correlates to their anti-inflammatory activity in vivo . This not only explained the beneficial activity of NSAIDs but also their side effects such as gastrointestinal toxicity and bleeding because prostaglandins and related molecules (i.e. thromboxane) are involved in a very broad range of physiological and pathophysiological responses. The importance of these molecules as autocrine and paracrine mediators has been confirmed recently by the phenotypes of mice bearing targeted deletions inCOX genes or prostaglandin receptor genes. The discovery of a second gene (COX-2 ) coding for cyclooxygenase and the demonstration that its protein product is distributed differently from the originally discovered enzyme (COX-1) raised the possibility that some of the beneficial effects of NSAIDs may be separable from their side effects by development of isoform-selective inhibitors (6Fu J.-Y. Masferrer J.L. Seibert K. Raz A. Needleman P. J. Biol. Chem. 1990; 265: 16737-16740Abstract Full Text PDF PubMed Google Scholar, 7Xie W. Chipman J.G. Robertson D.L. Erikson R.L. Simmons D.L. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 2692-2696Crossref PubMed Scopus (1686) Google Scholar, 8Kujubu D.A. Fletcher B.S. Varnum B.C. Lim R.W. Herschman H.R. J. Biol. Chem. 1991; 266: 12866-12872Abstract Full Text PDF PubMed Google Scholar, 9O'Banion M.K. Sadowski H.B. Winn V. Young D.A. J. Biol. Chem. 1991; 266: 23261-23267Abstract Full Text PDF PubMed Google Scholar). This hypothesis has been dramatically validated by the demonstration that selective COX-2 inhibitors are anti-inflammatory and analgesic but lack the gastric toxicity associated with all currently available NSAIDs (10Masferrer J.L. Zweifel B.S. Manning P.T. Hauser S.D. Leahy K.M. Smith W.G. Isakson P.C. Seibert K. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 3228-3232Crossref PubMed Scopus (1290) Google Scholar, 11Simon L.S. Lanza F.L. Lipsky P.E. Hubbard R.C. Talwalker S. Schwartz B.D. Isakson P.C. Geis G.S. Arthritis Rheum. 1998; 41: 1591-1602Crossref PubMed Scopus (490) Google Scholar). Substantial evidence supports the hypothesis that COX oxygenates arachidonic acid by a free radical mechanism (Fig. 1). Thus, COX appears to have co-opted the process that gives rise to isoprostanes to generate prostaglandins. The major differences between COX-catalyzed and spontaneous oxidation of arachidonic acid are the increased rate and high degree of stereochemical control of the enzymatic reaction (1 of 64 possible isomers predominates). Thus, the overall role of COX is rather simple: stereospecifically remove the 13-pro-S -hydrogen and control the stereochemistry of oxygenation. How does it do this? A protein tyrosyl radical appears to be the oxidizing agent that initiates arachidonic acid oxygenation (12Karthein R. Dietz R. Nastainczyk W. Ruf H.H. Eur. J. Biochem. 1988; 171: 313-320Crossref PubMed Scopus (231) Google Scholar). A tyrosyl radical is formed during COX turnover, and although there has been debate over
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Protein Radicals in Enzyme Catalysis
Stubbe, J., & van der Donk, W. A. (1998) · Chemical Reviews · doi:10.1021/cr9400875 · Cited by 1,377
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,265
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
Hamberg, M., Svensson, J., Wakabayashi, T., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.2.345 · Cited by 989
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Isolation and properties of intermediates in prostaglandin biosynthesis
Nugteren, D. H., & Hazelhof, E. (1973) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(73)90145-8 · Cited by 789
Detection and Isolation of an Endoperoxide Intermediate in Prostaglandin Biosynthesis
Hamberg, M., & Samuelsson, B. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.899 · Cited by 641
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 618
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
O'Banion, M. K., Sadowski, H. B., Winn, V., & Young, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54491-4 · Cited by 557
Loll, P. J., Picot, D., & Garavito, R. M. (1995) · Nature Structural Biology · doi:10.1038/nsb0895-637 · Cited by 490
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.
DeWitt, D. L., el-Harith, E. A., Kraemer, S. A., Andrews, M. J., Yao, E. F., Armstrong, R. L., & Smith, W. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34105-5 · Cited by 429
Landino, L. M., Crews, B. C., Timmons, M. D., Morrow, J. D., & Marnett, L. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15069 · Cited by 427
Self-citationGierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2
Yu, M., Ives, D., & Ramesha, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21181 · Cited by 404
On the Mechanism of the Biosynthesis of Prostaglandins E1 and F1α
Hamberg, M., & Samuelsson, B. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99433-0 · Cited by 402
Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.
Lecomte, M., Laneuville, O., Ji, C., DeWitt, D. L., & Smith, W. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36820-5 · Cited by 371
Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2
Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19330 · Cited by 301
KARTHEIN, R., DIETZ, R., NASTAINCZYK, W., & RUF, H. H. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13792.x · Cited by 284
Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 258
Self-citationDIETZ, R., NASTAINCZYK, W., & RUF, H. H. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13793.x · Cited by 256
Regulation of prostaglandin production by nitric oxide; an in vivo analysis
Salvemini, D., Settle, S. L., Masferrer, J. L., Seibert, K., Currie, M. G., & Needleman, P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13330.x · Cited by 240
Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis
Shimokawa, T., Kulmacz, R. J., DeWitt, D. L., & Smith, W. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30468-4 · Cited by 229
Bhattacharyya, D. K., Lecomte, M., Rieke, C. J., Garavito, R. M., & Smith, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2179 · Cited by 185
Gunther, M. R., Hsi, L. C., Curtis, J. F., Gierse, J. K., Marnett, L. J., Eling, T. E., & Mason, R. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17086 · Cited by 166
Self-citationLoll, P. J., Picot, D., Ekabo, O., & Garavito, R. M. (1996) · Biochemistry · doi:10.1021/bi952776w · Cited by 164
Acetylation of Prostaglandin Endoperoxide Synthetase with Acetylsalicylic Acid
OUDERAA, F. J., BUYTENHEK, M., NUGTEREN, D. H., & VAN DORP, D. A. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb04760.x · Cited by 160
Spectral properties of the higher oxidation states of prostaglandin H synthase.
Lambeir, A. M., Markey, C. M., Dunford, H. B., & Marnett, L. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95676-0 · Cited by 159
Self-citationMancini, J. A., Riendeau, D., Falgueyret, J., Vickers, P. J., & O’Neill, G. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29372 · Cited by 141
Wong, E., Bayly, C. I., Waterman, H. L., Riendeau, D., & Mancini, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9280 · Cited by 131
Goodwin, D. C., Gunther, M. R., Hsi, L. C., Crews, B. C., Eling, T. E., Mason, R. P., & Marnett, L. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8903 · Cited by 125
Self-citationSmith, W. L., Eling, T. E., Kulmacz, R. J., Marnett, L. J., & Tsai, A.-L. (1992) · Biochemistry · doi:10.1021/bi00116a001 · Cited by 122
Self-citationXiao, G., Tsai, A.-L., Palmer, G., Boyar, W. C., Marshall, P. J., & Kulmacz, R. J. (1997) · Biochemistry · doi:10.1021/bi962476u · Cited by 121
Kalgutkar, A. S. S., Kozak, K. R., Crews, B. C., Hochgesang, G. P., & Marnett, L. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980303s · Cited by 118
Self-citationDesign of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents
Marnett, L. J., & Kalgutkar, A. S. S. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80124-5 · Cited by 116
Self-citationGuo, Q., Wang, L., Ruan, K., & Kulmacz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19134 · Cited by 114
Chapter 21. Selective Cyclooxygenase-2 Inhibitors
Prasit, P., & Riendeau, D. (1997) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61479-7 · Cited by 96
The Dynamics of Prostaglandin H Synthases
So, O., Scarafia, L. E., Mak, A. Y., Callan, O., & Swinney, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5801 · Cited by 91
Spectral analysis of the protein-derived tyrosyl radicals from prostaglandin H synthase.
DeGray, J. A., Laßmann, G., Curtis, J. F., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35878-2 · Cited by 82
Tsai, A., Palmer, G., Xiao, G., Swinney, D. C., & Kulmacz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3888 · Cited by 77
Comparison of branched-chain and tightly coupled reaction mechanisms for prostaglandin H synthase
Wei, C., Kulmacz, R. J., & Tsai, A. (1995) · Biochemistry · doi:10.1021/bi00026a034 · Cited by 57
Selective inhibitors of cyclooxygenase-2
Talley, J. J. (1997) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.7.1.55 · Cited by 55
Munroe, D. G., & Lau, C. Y. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90212-0 · Cited by 29
Stoichiometry of the Interaction of Prostaglandin H Synthase with Substrates
Tsai, A., Wu, G., & Kulmacz, R. J. (1997) · Biochemistry · doi:10.1021/bi970397s · Cited by 20
Tang, M. S., Copeland, R. A., & Penning, T. M. (1997) · Biochemistry · doi:10.1021/bi962750k · Cited by 14
Cited by
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Metadata
- Authors
- Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S., & Lanzo, C. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 274
- Issue
- 33
- Pages
- 22903-22906
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2066395665
- Cited by
- 523
- References
- 52
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.